Gene Expression Differences Between Matched Pairs of Ovarian Cancer Patient Tumors and Patient-Derived Xenografts

Scientific Reports- United Kingdom

doi 10.1038/s41598-019-42680-2

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Patient-Derived Breast Tumor Xenografts Facilitating Personalized Cancer Therapy

Breast Cancer Research
Cancer ResearchOncology
2013English

Targeting HER2 in Patient-Derived Xenograft Ovarian Cancer Models Sensitizes Tumors to Chemotherapy

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2018English

P1.04-08 Co-Residence of Patient-Derived Immune Cells in Patient-Derived Xenografts From Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Establishment of Patient-Derived Xenografts in Mice

BIO-PROTOCOL
2016English

Identification of Synergistic Drug Combinations Using Breast Cancer Patient-Derived Xenografts

Scientific Reports
Multidisciplinary
2020English

Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison With Patient Clinical Data

Cancer Research
Cancer ResearchOncology
2015English

Pharmacological Inhibition of P38 MAPK Reduces Tumor Growth in Patient-Derived Xenografts From Colon Tumors

Oncotarget
Oncology
2015English

Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma

Cancers
Cancer ResearchOncology
2020English

Establishment and Characterization of Patient-Derived Xenografts as Paraclinical Models for Head and Neck Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy